Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04714398 · ClinicalTrials.gov registry record · NA
SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management
A NA study of Hypertension, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 425
- Enrollment target
- 1
- Study location
NCT04714398: Completed NA study of Hypertension, sponsored by University of Pennsylvania.
NCT04714398 is a NA study of Hypertension that has completed, run by University of Pennsylvania. The registered enrollment target is 425 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04714398, a NA study of Hypertension, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 425 participants
- Enrollment target
- 1
- Study location
Study Summary
A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).
Primary Outcome
The proportion of patients participating in each study arm out of the number randomized to that study arm.
Conditions Studied
Interventions
- BEHAVIORAL Opt-In Recruitment
- BEHAVIORAL Opt-Out Recruitment
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2022-08-26 |
| Phase | NA |
What the finished NCT04714398 record still lists
NCT04714398 is an interventional study that assigns participants to a tested intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Opt-In Recruitment is the first listed.
NCT04714398 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04714398 about?
NCT04714398 is a clinical study titled "SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management". A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).
What is the current status of trial NCT04714398?
This trial is currently completed. It is a NA study. The enrollment target is 425 participants. The study started on 2021-02-26. Estimated completion is 2022-08-26.
What conditions does trial NCT04714398 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT04714398?
The interventions under investigation include: Opt-In Recruitment (BEHAVIORAL), Opt-Out Recruitment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04714398?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04714398 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04714398's enrollment target sits among peer trials
425 141st of 470 higher than 329 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
- NCT06693687 · 425 participants · NA
A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI